This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Oventus Medical Management

Management criteria checks 2/4

Key information

John Cox

Chief executive officer

AU$517.5k

Total compensation

CEO salary percentage6.7%
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenure1.3yrs
Board average tenure4yrs

Recent management updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Nov 11
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Nov 11
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now

Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

May 09
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Jan 24
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?

Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term

Nov 30
Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term

CEO Compensation Analysis

How has John Cox's remuneration changed compared to Oventus Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2021n/an/a

-AU$10m

Sep 30 2021n/an/a

-AU$10m

Jun 30 2021AU$517kAU$34k

-AU$10m

Compensation vs Market: John's total compensation ($USD354.03K) is about average for companies of similar size in the Australian market ($USD282.66K).

Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.


CEO

John Cox

1.3yrs

Tenure

AU$517,485

Compensation

Mr. John Cox has been President and Chief Operating Officer of Oventus Medical Limited since June 7, 2021 and serves as its Chief Executive Officer since February 1, 2022. He serves as President and Chief...


Leadership Team

NamePositionTenureCompensationOwnership
John Cox
CEO, President & COO1.3yrsAU$517.49kno data
James Hunter
Acting Chief Financial Officer1.3yrsAU$202.85kno data
Stephen Denaro
Company Secretary6.9yrsAU$63.05k0.14%
A$ 6.9k
Greg Eaton
Vice President Salesno datano datano data

1.3yrs

Average Tenure

Experienced Management: OVN's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Richard Bogan
Member of Medical Technology Advisory Board4yrsno datano data
Jason Nunn
Non-Executive Director2.6yrsAU$194.84k0.15%
A$ 7.3k
Paul Molloy
Non-Executive Director2.8yrsAU$191.53k0.22%
A$ 10.4k
Susan MacLeman
Independent Non-Executive Chairman6.8yrsAU$162.29k0.093%
A$ 4.5k
Lee Surkin
Member of Medical Technology Advisory Board4yrsno datano data
Jerrold Kram
Member of Medical Technology Advisory Board4yrsno datano data
Mark Hickey
Member of Medical Technology Advisory Board4yrsno datano data
Mark Rasmus
Member of Medical Technology Advisory Board4yrsno datano data
Daniel Brown
Member of Medical Technology Advisory Board4yrsno datano data
Myra Brown
Member of Medical Technology Advisory Board4yrsno datano data
Pedro Cuartas
Medical Technology Advisory Board Member3.3yrsno datano data

4.0yrs

Average Tenure

59yo

Average Age

Experienced Board: OVN's board of directors are considered experienced (4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/09/04 11:59
End of Day Share Price 2022/06/07 00:00
Earnings2021/12/31
Annual Earnings2021/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oventus Medical Limited is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martyn JacobsCanaccord Genuity